The biopharma industry’s business model now depends structurally and irreversibly on multi-party execution. Scientific, regulatory, political, and commercial conditions have converged to create unprecedented interdependence. Modalities are more diverse. Clinical...
Collaboration
A Spotlight on Maximizing Alliance Value Realization
Alliances have long been a core strategy of biopharmaceutical companies. From early-stage biotech discovery partnerships to global codevelopment and cocommercialization pacts, these collaborations create value for the partners by accelerating drug development,...
Reimagining Stakeholder Engagement: Creating Value and Driving Impact
Historically, alliance professionals have faced challenges engaging senior executives effectively. Too often, interactions center on routine updates rather than forward-looking, strategic discussions. At the 2025 ASAP Summit in Denver, Jan Twombly shared techniques to...
As Seen in Strategic Alliance Quarterly: Better Team Collaboration Means Better Alliance Outcomes
Collaboration Is Not a Discrete Skill but a Way of Working—and the Data Shows That Improving Your Teams’ Collaboration Leads to Improved Alliance Results. ...
Bridging Philosophical Differences in an Alliance
What happens when companies in an alliance find they have significant philosophical differences they just can’t align? It can be a recipe for stalemate and escalation. Decisions are delayed and value is lost. These differences can often be hard to uncover, hidden by...
Techniques for Consensus Decision Making
Alliances frequently operate with consensus decision making. Explore the benefits and challenges of achieving consensus. Learn techniques that will help your alliance make the best decisions it can.
Breaking the Collaboration Paradox: A Leadership Requirement for the Next Normal
The following post was initially published by The Drucker Forum as part of its "Shape the Debate" discussion concurrent with the 12th Global Peter Drucker Forum, Leadership Everywhere, A Fresh Perspective on Management. There are some things we’ve learned in the past...
Exemplary Alliance, Ordinary Practices
The statistics are daunting. Drug development has an overall failure rate of over 96%. It is especially acute for some of the most debilitating diseases where the biological mechanism that causes the disease state is not well understood. Spreading that risk...
Collaboration: Conceptually Simple, Operationally Challenging
Collaboration is one of the most misunderstood and overused concepts in business today. There are many perspectives on what it is, ranging from the simplistic—working with other people to produce an outcome—to the complexity of the latest technical platform that...









